NO992710D0 - FremgangsmÕte for fremstilling av metallkomplekskarboksylsyreamider - Google Patents

FremgangsmÕte for fremstilling av metallkomplekskarboksylsyreamider

Info

Publication number
NO992710D0
NO992710D0 NO992710A NO992710A NO992710D0 NO 992710 D0 NO992710 D0 NO 992710D0 NO 992710 A NO992710 A NO 992710A NO 992710 A NO992710 A NO 992710A NO 992710 D0 NO992710 D0 NO 992710D0
Authority
NO
Norway
Prior art keywords
carboxylic acid
metal complex
complex carboxylic
acid amides
preparation
Prior art date
Application number
NO992710A
Other languages
English (en)
Other versions
NO992710L (no
NO312724B1 (no
Inventor
Heribert Schmitt-Willich
Johannes Platzek
Klaus-Dieter Graske
Chel Bernd Rad
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO992710L publication Critical patent/NO992710L/no
Publication of NO992710D0 publication Critical patent/NO992710D0/no
Publication of NO312724B1 publication Critical patent/NO312724B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/143—Peptides, e.g. proteins the protein being an albumin, e.g. HSA, BSA, ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/146—Peptides, e.g. proteins the peptide being a polyamino acid, e.g. poly-lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19992710A 1996-12-04 1999-06-03 Fremgangsmåte for fremstilling av metallkomplekskarboksylsyreamider NO312724B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19652386A DE19652386A1 (de) 1996-12-04 1996-12-04 Verfahren zur Herstellung von Metallkomplexcarbonsäureamiden
PCT/EP1997/006594 WO1998024775A1 (de) 1996-12-04 1997-11-26 Verfahren zur herstellung von metallkomplexcarbonsäureamiden

Publications (3)

Publication Number Publication Date
NO992710L NO992710L (no) 1999-06-03
NO992710D0 true NO992710D0 (no) 1999-06-03
NO312724B1 NO312724B1 (no) 2002-06-24

Family

ID=7814928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992710A NO312724B1 (no) 1996-12-04 1999-06-03 Fremgangsmåte for fremstilling av metallkomplekskarboksylsyreamider

Country Status (12)

Country Link
EP (1) EP0946525B1 (no)
JP (1) JP4278182B2 (no)
AT (1) ATE263758T1 (no)
AU (1) AU5556698A (no)
DE (2) DE19652386A1 (no)
DK (1) DK0946525T3 (no)
ES (1) ES2218711T3 (no)
NO (1) NO312724B1 (no)
PT (1) PT946525E (no)
TW (1) TW438804B (no)
WO (1) WO1998024775A1 (no)
ZA (1) ZA9710930B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19905094C1 (de) * 1999-02-01 2000-10-12 Schering Ag Gadolinium (III)-Komplexe sowie ihre Verwendung für Zweischritt Strahlentherapieformen und diese enthaltende pharmazeutische Mittel
DE10105014C2 (de) * 2001-01-26 2003-03-27 Schering Ag Neues Verfahren zur Herstellung von Monoamiden der DTPA
FR2856063B1 (fr) * 2003-06-13 2005-10-07 Air Liquide Procede de preparation du cis-8b-methyldecahydro-2a,4a,6a, 8a-tetraazacyclopenta[fg]acenaphthylene,ou du cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg] acenaphthylene, du cyclene, et de cyclenes fonctionnalises
DE102007002726A1 (de) 2007-01-18 2008-07-31 Bayer Schering Pharma Aktiengesellschaft Neue Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
KR101334780B1 (ko) 2010-08-13 2013-12-02 한국생명공학연구원 요오드를 함유한 방사형상의 고분자 화합물, 이의 제조방법 및 이를 포함하는 ｃｔ용 조영제 조성물
WO2014124943A1 (en) 2013-02-12 2014-08-21 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
EP3101012A1 (en) * 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
KR102464647B1 (ko) 2016-11-28 2022-11-08 바이엘 파마 악티엔게젤샤프트 자기 공명 영상화에 사용하기 위한 높은 이완도 가돌리늄 킬레이트 화합물
CN113164628A (zh) 2018-11-23 2021-07-23 拜耳股份有限公司 造影介质制剂及其制备方法
CN111004623B (zh) * 2019-12-20 2023-07-18 河北科技大学 一种卟啉类荧光材料及其制备方法
EP4360660A1 (en) 2022-10-24 2024-05-01 Bayer AG Process for the preparation of a gadolinium contrast agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316757A (en) * 1984-10-18 1994-05-31 Board Of Regents, The University Of Texas System Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
DE3625417C2 (de) * 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
DE4218744C2 (de) * 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe

Also Published As

Publication number Publication date
NO992710L (no) 1999-06-03
TW438804B (en) 2001-06-07
AU5556698A (en) 1998-06-29
NO312724B1 (no) 2002-06-24
DK0946525T3 (da) 2004-08-02
ATE263758T1 (de) 2004-04-15
EP0946525A1 (de) 1999-10-06
DE59711504D1 (de) 2004-05-13
PT946525E (pt) 2004-08-31
WO1998024775A1 (de) 1998-06-11
DE19652386A1 (de) 1998-06-10
ES2218711T3 (es) 2004-11-16
ZA9710930B (en) 1998-09-08
JP4278182B2 (ja) 2009-06-10
EP0946525B1 (de) 2004-04-07
JP2001504844A (ja) 2001-04-10

Similar Documents

Publication Publication Date Title
NO992710D0 (no) FremgangsmÕte for fremstilling av metallkomplekskarboksylsyreamider
DE69433010D1 (de) Verfahren zur darstellung von oligonukleotiden
ATE136899T1 (de) Verfahren zur herstellung eines n- phenylacetylderivats von tetrahydrothieno(3,2- c>pyridin und zwischenprodukt der synthese
ATE317912T1 (de) Verfahren zur herstellung von beta-lactamen
ATE144493T1 (de) Verfahren und herstellung von salicylaldoxim- derivaten
HUT77178A (hu) Szubsztituált 3-amino-benzonitrilek, eljárás előállításukra, és eljárás benzatiadiazol-7-karboxilsav előállítására
DK0619305T3 (da) Lactonforbindelse og fremgangsmåde til fremstilling deraf
EP0882767A4 (en) DISAZO CONNECTIONS AND THEIR PRODUCTION PROCESS
UA19056A (uk) Спосіб одержаhhя діамідів n,n-біс(алкоксіалкіл)-піридиh-2,4-дікарбоhової кислоти
NZ514653A (en) Process for producing an amide compound by reacting a compound with an amino group with a polyaminocarboxylic acid anhydride
HUP9801720A2 (hu) Új eljárás palatinit előállítására
DE3375569D1 (en) Improvement in the process for preparing biaryl compounds via coupling of an arylamine with an arene
UA8032A1 (uk) Спосіб одержання 2-(4-метоксіфенілпропіоніл)аміно-6-н-пропіламіно-4,5,6,7-тетрагідробензотіазола у вигляді рацемата або (-)-енантіомера або його кислотно-аддітивної солі
DK0700294T3 (da) Injektionsopløsning til intramuskulær og subkutan indgivelse i dyr
HK1027560A1 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
KR920016441A (ko) 글리세르알데하이드-3-펜타나이드 및 이의 제조방법
ATE159519T1 (de) Verfahren zur herstellung von n-phenyl-n-(4- piperidinyl)amid-derivaten
ES2082703A1 (es) Nuevos derivados de ciclopropilo, procedimientos para su preparacion y aplicaciones.
IL141010A (en) Method for producing atropic acid ethyl ester
ATE366255T1 (de) Verfahren zur herstellung halogenierter beta- lactamverbindungen
EP0106282A3 (en) Production of caerulein intermediate
BG101525A (en) Method for the preparation of aromatic o-sulphocarboxylic aicds and sulphonylcarbamides
MY124079A (en) Process for producing 1, 2-dimethyl-3-hydroxypyrid-4- one
MX9605321A (es) Proceso para la preparacion de 4-amino-a4-amino-a3-cetoesteroides via 4-nitro-a4-cetoesteroides.
YU78793A (sh) N-cikloalkil amidi privalinske kiseline i postupak za njihovo dobijanje

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees